Min Yi

机构：Shandong University of Technology, Zibo Vocational Institute, The University of Texas MD Anderson Cancer Center, Central South University, Guangdong Medical College, Hainan University, Astellas Pharma (South Korea), Second Xiangya Hospital of Central South University, New York University, IMU University, University of Pennsylvania, Hainan Medical University · ORCID：0000-0001-8662-6546

发表论文 254 篇 · 总被引 7550 次 · h-index 49

代表论文

• IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer (2025 · npj Precision Oncology · 被引 14)
• Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy (2024 · Annals of Surgical Oncology · 被引 7)
• UBC9-associated SUMOylation contributes to β-catenin activation and kidney fibrosis (2025 · Kidney International · 被引 5)
• SUMOylation protects against sepsis-associated acute kidney injury by stabilizing IκBα (2025 · Molecular Therapy · 被引 4)
• Single-cell transcriptomic analysis reveals the heterogeneity and functional characteristics of macrophage subpopulations in colon cancer (2025 · Discover Oncology · 被引 2)
• From an Antimicrobial Agent to a constituent of 3D Printed Heterogenous Scaffolds Stimulating Bone Characteristics: An In-vitro and Animal model evaluation (2025 · Regenerative Therapy · 被引 2)